Dormant Wnt-initiated mammary cancer can participate in reconstituting functional mammary glands

Molecular and Cellular Biology

Volumn 27, Issue 1, 2007, Pages 195-207

  Gestl, Shelley A ^a   Leonard, Travis L ^a   Biddle, Jessica L ^a   Debies, Michael T ^a   Gunther, Edward J ^a,b  

^a PENN STATE CANCER INSTITUTE   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; FAT; HORMONE; WNT PROTEIN; WNT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST DUCT; BREAST EPITHELIUM; CANCER DORMANCY; CANCER INVASION; CANCER REGRESSION; CANCER RELAPSE; CANCER STEM CELL; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE MUTATION; GENETIC RECOMBINATION; HISTOLOGY; HYPERPLASIA; IN VIVO STUDY; MAMMARY GLAND; MINIMAL RESIDUAL DISEASE; MORPHOLOGY; MOUSE; NONHUMAN; ONCOGENE H RAS; PREGNANCY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE DIFFERENTIATION; TISSUE GRAFT; TISSUE GROWTH; TISSUE REGENERATION; TRANSGENIC MOUSE; TUMOR CELL CULTURE;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; DISEASE MODELS, ANIMAL; DOXYCYCLINE; EPITHELIUM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HORMONES; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, TRANSGENIC; REMISSION INDUCTION; SIGNAL TRANSDUCTION; WNT PROTEINS;

MUS MUSCULUS;

EID: 33845800844     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01525-06     Document Type: Article

References (42)

1. Al-Hajj, M., M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke. 2003. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 100:3983-3988.
2. Anonymous. 2000. Adjuvant therapy for breast cancer. NIH Consensus Statement 17:1-35.
3. Anonymous. 1992. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet 339:71-85.
4. Aoki, Y., T. Niihori, H. Kawame, K. Kurosawa, H. Ohashi, Y. Tanaka, M. Filocamo, K. Kato, Y. Suzuki, S. Kure, and Y. Matsubara. 2005. Germline mutations in HRAS proto-oncogene cause Costello syndrome. Nat. Genet. 37:1038-1040.
5. Bafico, A., G. Liu, L. Goldin, V. Harris, and S. A. Aaronson. 2004. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 6:497-506.
6. Beachy, P. A., S. S. Karhadkar, and D. M. Berman. 2004. Tissue repair and stem cell renewal in carcinogenesis. Nature 432:324-331.
7. Boxer, R. B., J. W. Jang, L. Sintasath, and L. A. Chodosh. 2004. Lack of sustained regression of c-MYC-induced mammary adenocarcinomas following brief or prolonged MYC inactivation. Cancer Cell 6:577-586.
8. Braun, S., F. D. Vogl, B. Naume, W. Janni, M. P. Osborne, R. C. Coombes, G. Schlimok, I. J. Diel, B. Gerber, G. Gebauer, J. Y. Pierga, C. Marth, D. Oruzio, G. Wiedswang, E. F. Solomayer, G. Kundt, B. Strobl, T. Fehm, G. Y. Wong, J. Bliss, A. Vincent-Salomon, and K. Pantel. 2005. A pooled analysis of bone marrow micrometastasis in breast cancer. N. Engl. J. Med. 353:793-802.
9. Brisken, C., A. Heineman, T. Chavarria, B. Elenbaas, J. Tan, S. K. Dey, J. A. McMahon, A. P. McMahon, and R. A. Weinberg. 2000. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev. 14:650-654.
10. Chin, L., A. Tam, J. Pomerantz, M. Wong, J. Holash, N. Bardeesy, Q. Shen, R. O'Hagan, J. Pantginis, H. Zhou, J. W. Horner II, C. Cordon-Cardo, G. D. Yancopoulos, and R. A. DePinho. 1999. Essential role for oncogenic Ras in tumour maintenance. Nature 400:468-472.
11. D'Cruz, C. M., E. J. Gunther, R. B. Boxer, J. L. Hartman, L. Sintasath, S. E. Moody, J. D. Cox, S. I. Ha, G. K. Belka, A. Golant, R. D. Cardiff, and L. A. Chodosh. 2001. c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat. Med. 7:235-239.
12. Demicheli, R. 2001. Tumour dormancy: findings and hypotheses from clinical research on breast cancer. Semin. Cancer Biol. 11:297-306.
13. Demicheli, R., M. Terenziani, P. Valagussa, A. Moliterni, M. Zambetti, and G. Bonadonna. 1994. Local recurrences following mastectomy: support for the concept of tumor dormancy. J. Natl. Cancer Inst. 86:45-48.
14. Dontu, G., M. Al-Hajj, W. M. Abdallah, M. F. Clarke, and M. S. Wicha. 2003. Stem cells in normal breast development and breast cancer. Cell Prolif. 36(Suppl. 1):59-72.
15. Fuchs, E., T. Tumbar, and G. Guasch. 2004. Socializing with the neighbors: stem cells and their niche. Cell 116:769-778.
16. Gudjonsson, T., R. Villadsen, H. L. Nielsen, L. Ronnov-Jessen, M. J. Bissell, and O. W. Petersen. 2002. Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties. Genes Dev. 16:693-706.
17. Gunther, E. J., S. E. Moody, G. K. Belka, K. T. Hahn, N. Innocent, K. D. Dugan, R. D. Cardiff, and L. A. Chodosh. 2003. Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev. 17:488-501.
18. Hochedlinger, K., R. Blelloch, C. Brennan, Y. Yamada, M. Kim, L. Chin, and R. Jaenisch. 2004. Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev. 18:1875-1885.
19. Huang, E., S. Ishida, J. Pittman, H. Dressman, A. Bild, M. Kloos, M. D'Amico, R. G. Pestell, M. West, and J. R. Nevins. 2003. Gene expression phenotypic models that predict the activity of oncogenic pathways. Nat. Genet. 34:226-230.
20. Joseph, N. M., and S. J. Morrison. 2005. Toward an understanding of the physiological function of mammalian stem cells. Dev. Cell 9:173-183.
21. Kordon, E. C., and G. H. Smith. 1998. An entire functional mammary gland may comprise the progeny from a single cell. Development 125:1921-1930.
22. Li, Y., B. Welm, K. Podsypanina, S. Huang, M. Chamorro, X. Zhang, T. Rowlands, M. Egeblad, P. Cowin, Z. Werb, L. K. Tan, J. M. Rosen, and H. E. Varmus. 2003. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc. Natl. Acad. Sci. USA 100:15853-15858.
23. Liu, B. Y., S. P. McDermott, S. S. Khwaja, and C. M. Alexander. 2004. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc. Natl. Acad. Sci. USA 101:4158-4163.
24. Miyoshi, K., J. M. Shillingford, F. Le Provost, F. Gounari, R. Bronson, H. von Boehmer, M. M. Taketo, R. D. Cardiff, L. Hennighausen, and K. Khazaie. 2002. Activation of beta-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc. Natl. Acad. Sci. USA 99:219-224.
25. Moody, S. E., D. Perez, T. C. Pan, C. J. Sarkisian, C. P. Portocarrero, C. J. Sterner, K. L. Notorfrancesco, R. D. Cardiff, and L. A. Chodosh. 2005. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8:197-209.
26. Nusse, R., A. van Ooyen, D. Cox, Y. K. Fung, and H. Varmus. 1984. Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature 307:131-136.
27. Pardal, R., M. F. Clarke, and S. J. Morrison. 2003. Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3:895-902.
28. Podsypanina, K., Y. Li, and H. E. Varmus. 2004. Evolution of somatic mutations in mammary tumors in transgenic mice is influenced by the inherited genotype. BMC Med. 2:24.
29. Rangarajan, A., S. J. Hong, A. Gifford, and R. A. Weinberg. 2004. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6:171-183.
30. Reya, T., and H. Clevers. 2005. Wnt signaling in stem cells and cancer. Nature 434:843-850.
31. Reya, T., S. J. Morrison, M. F. Clarke, and I. L. Weissman. 2001. Stem cells, cancer, and cancer stem cells. Nature 414:105-111.
32. Riethmuller, G., and C. A. Klein. 2001. Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. Semin. Cancer Biol. 11:307-311.
33. Rosner, A., K. Miyoshi, E. Landesman-Bollag, X. Xu, D. C. Seldin, A. R. Moser, C. L. MacLeod, G. Shyamala, A. E. Gillgrass, and R. D. Cardiff. 2002. Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors. Am. J. Pathol. 161:1087-1097.
34. Shachaf, C. M., A. M. Kopelman, C. Arvanitis, A. Karlsson, S. Beer, S. Mandl, M. H. Bachmann, A. D. Borowsky, B. Ruebner, R. D. Cardiff, Q. Yang, J. M. Bishop, C. H. Contag, and D. W. Felsher. 2004. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431:1112-1117.
35. Shackleton, M., F. Vaillant, K. J. Simpson, J. Stingl, G. K. Smyth, M. L. Asselin-Labat, L. Wu, G. J. Lindeman, and J. E. Visvader. 2006. Generation of a functional mammary gland from a single stem cell. Nature 439:84-88.
36. Sinn, E., W. Muller, P. Pattengale, I. Tepler, R. Wallace, and P. Leder. 1987. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49:465-475.
37. Smith, G. H., and D. Medina. 1988. A morphologically distinct candidate for an epithelial stem cell in mouse mammary gland. J. Cell Sci. 90:173-183.
38. Stingl, J., P. Eirew, I. Ricketson, M. Shackleton, F. Vaillant, D. Choi, H. I. Li, and C. J. Eaves. 2006. Purification and unique properties of mammary epithelial stem cells. Nature 439:993-997.
39. Taipale, J., and P. A. Beachy. 2001. The Hedgehog and Wnt signaling pathways in cancer. Nature 411:349-354.
40. Uhr, J. W., R. H. Scheuermann, N. E. Street, and E. S. Vitetta. 1997. Cancer dormancy: opportunities for new therapeutic approaches. Nat. Med. 3:505-509.
41. Weissman, I. L., D. J. Anderson, and F. Gage. 2001. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu. Rev. Cell Dev. Biol. 17:387-403.
42. Wiseman, B. S., and Z. Werb. 2002. Stromal effects on mammary gland development and breast cancer. Science 296:1046-1049.